Novo Nordisk posts strong late-stage results for oral diabetes pill in children and teens
The study evaluated oral semaglutide in young patients with type 2 diabetes and found it delivered a superior reduction in HbA1c
The study evaluated oral semaglutide in young patients with type 2 diabetes and found it delivered a superior reduction in HbA1c
The ETHICON 4000 Stapler and ETHICON 3D Reloads are now approved for use in both open and laparoscopic surgeries across the European Union
These findings help explain how relapse-triggering memories can persist alongside those that support recovery
The study is being conducted through its Japan-based pharmaceutical arm, Asahi Kasei Therapeutics Corp
SBE303 targets Nectin-4, an adhesion protein overexpressed in multiple tumor types, including urothelial, lung, and breast cancers
The newly formed SAB will provide strategic direction across research, clinical development, and regulatory pathways
The launch coincides with IBS Awareness Month in April
Genome editing holds extraordinary promise for treating previously incurable genetic diseases
Dr Shivkumar Kalyanaraman emphasizes need for quality research, partnerships, and measurable outcomes
4th World Homoeopathy Summit at Palace of Westminster and University of Oxford spotlights integrative healthcare and global collaboration
Subscribe To Our Newsletter & Stay Updated